Patient Journey 2.0: The Re-Remix! A fresh take on health and integrating primary and real-world data

As drug development timelines accelerate and therapy areas continue to evolve, cross-functional teams must align on shared outputs more than ever. With the increasing number of supplemental indication approvals, brands require fresh insights for each new scenario. Moreover, the complexity of rare patient populations underscores the need for a novel approach.

Fortunately, we now have access to an array of data sources—from primary research to social media, claims data to electronic health records (EHRs), and beyond. The challenge lies in harnessing this wealth of information to construct a coherent narrative.

Join our panel from KMK Consulting, renowned for their global expertise in Primary Market Research and Real-World Data analytics. Together, we’ll explore what the industry still requires from patient journey research and unveil innovative approaches. This time, we’re reimagining the patient journey through an integrated lens, leveraging a range of real-world and primary data sources to craft one robust, actionable, and flexible narrative.

What you’ll learn:

• Understanding the evolving needs of large cross-functional pharma teams
• Harnessing diverse data sources to construct a coherent patient journey narrative
• Unveiling novel approaches to patient journey research
• Addressing the challenges and opportunities of integrating primary and real-world data